Protection Against Adoptive Transfer of Autoimmune Diabetes Mediated Through Very Late Antigen-4 Integrin
暂无分享,去创建一个
[1] D. Mason,et al. Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential , 1993, The Journal of experimental medicine.
[2] H. Drexhage,et al. Dendritic Cells and Scavenger Macrophages in Pancreatic Islets of Prediabetic BB Rats , 1989, Diabetes.
[3] R. McEver. Adhesion: Its role in inflammatory disease , 1992 .
[4] A. Rabinovitch,et al. Destruction of Rat Islet Cell Monolayers by Cytokines: Synergistic Interactions of Interferon-γ, Tumor Necrosis Factor, Lymphotoxin, and Interleukin 1 , 1988, Diabetes.
[5] G. Eisenbarth,et al. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. , 1990, Annual review of immunology.
[6] M. Elices,et al. Structure of the Integrin VLA‐4 and its Cell‐Cell and Cell‐Matrix Adhesion Functions , 1990, Immunological reviews.
[7] T. Issekutz. Effect of antigen challenge on lymph node lymphocyte adhesion to vascular endothelial cells and the role of VLA-4 in the rat. , 1991, Cellular immunology.
[8] C. Janeway,et al. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma , 1993, The Journal of experimental medicine.
[9] S. Gordon,et al. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages , 1990, Nature.
[10] W. Newman,et al. Activation-independent binding of human memory T cells to adhesion molecule ELAM-1 , 1991, Nature.
[11] R. Larson,et al. Structure and Function of Leukocyte Integrins , 1990, Immunological reviews.
[12] R. Cotran,et al. Identification of an inducible endothelial-leukocyte adhesion molecule. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[13] Cynthia A. Williams,et al. Monoclonal antibodies to the integrin α−4 subunit inhibit the murine contact hypersensitivity response , 1993, European journal of immunology.
[14] D. T. Bogue,et al. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. , 1991, Journal of immunology.
[15] K. Lafferty,et al. Combined Treatment With Nicotinamide and Desferrioxamine Prevents Islet Allograft Destruction in NOD Mice , 1986, Diabetes.
[16] F. Sánchez‐Madrid,et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin , 1992, Nature.
[17] L. Wicker,et al. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. , 1988, Journal of immunology.
[18] W. Carter,et al. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin , 1989, The Journal of cell biology.
[19] Michael Loran Dustin,et al. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). , 1986, Journal of immunology.
[20] A. Wardlaw,et al. Adhesion to fibronectin prolongs eosinophil survival , 1993, Journal of Experimental Medicine.
[21] K. Horgan,et al. Roles of Adhesion Molecules in T‐Cell Recognition: Fundamental Similarities between Four Integrins on Resting Human T Cells (LFA‐1, VLA‐4, VLA‐5, VLA‐6) in Expression, Binding, and Costimulation , 1990, Immunological reviews.
[22] H. Mcdevitt,et al. Antigen‐presenting cells in adoptively transferred and spontaneous autoimmune diabetes , 1993, European journal of immunology.
[23] G. Rice,et al. Vascular and nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues. , 1991, The American journal of pathology.
[24] L. Osborn,et al. Leukocyte adhesion to endothelium in inflammation , 1990, Cell.
[25] J. Seidman,et al. Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors. , 1993, Science.
[26] L. Burkly,et al. Signaling by vascular cell adhesion molecule‐1 (VCAM‐1) through VLA‐4 promotes CD3‐dependent T cell proliferation , 1991, European journal of immunology.
[27] L. Picker,et al. ELAM-1 is an adhesion molecule for skin-homing T cells , 1991, Nature.
[28] I. Weissman,et al. Identification of a murine Peyer's patch--specific lymphocyte homing receptor as an integrin molecule with an alpha chain homologous to human VLA-4 alpha. , 1989, Cell.
[29] T. V. Gopal,et al. Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions , 1991, The Journal of cell biology.
[30] T. Issekutz. Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody. A likely role for VLA-4 in vivo. , 1991, Journal of immunology.
[31] J. Satoh,et al. Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice. , 1989, The Journal of clinical investigation.
[32] S. Haskill,et al. Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[33] C. Benjamin,et al. Expression and functional characterization of a soluble form of vascular cell adhesion molecule 1. , 1991, Biochemical and biophysical research communications.
[34] I. Weissman,et al. Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis , 1991, The Journal of experimental medicine.
[35] C. Jacob. Tumor necrosis factor α in autoimmunity: pretty girl or old witch? , 1992 .